Skip to content

The effect of Oral BUtyrate on human Glucose and brownfAT metabolism

The effect of Oral BUtyrate on human Glucose and brownfAT metabolism - OBUGAT study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38772
Enrollment
20
Registered
2014-01-07
Start date
2014-02-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brown adipose fat tissue insulin resistance

Interventions

A total of 20 subjects will be included in this study. Healthy lean male volunteers (N=10, age >18 years, BMI 19-25 kg/m2) and obese insulin resistant male volunteers (n=10, age >18 years, BMI>25) w

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Group A; lean healthy males, age >18 years, BMI 18-25 m/kg Group B: males, age> 18 years, BMI > 25 m/kg

Exclusion criteria

Exclusion criteria: Group A: smoking, use of medication, participation in a research protcol involving radiation exposure in the last 2 year. Group B: smoking, use of medication, participation in a research protocol involving radiation exposure in the last 2 years.

Design outcomes

Primary

MeasureTime frame
Differences in BAT activity (semi quantitative uptake value of the tracer FDG visualised with PET-CT) as well as insulin sensitivity (clamps)

Secondary

MeasureTime frame
- Correlation between resting energy expenditure before and after using butyrate (4g/day, 4 weeks) during thermoneutral conditions. - Changes in fecal gutmicrobiota and fecal energy excretion (triglycerides). - Changes in subcutaneous gene and protein expression of insulin phosphorylation signalling pathways, inflammatory markers and lipid homeostasis pathways.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)